Should the number of acute exacerbations in the previous year be used to guide treatments in COPD? M Sadatsafavi, J McCormack, J Petkau, LD Lynd, TY Lee, DD Sin European Respiratory Journal 57 (2), 2021 | 26 | 2021 |
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease AW Wong, TY Lee, KA Johannson, D Assayag, J Morisset, CD Fell, ... Respiratory Research 21, 1-9, 2020 | 24 | 2020 |
ACCEPT 2· 0: recalibrating and externally validating the acute COPD exacerbation prediction tool (ACCEPT) A Safari, A Adibi, DD Sin, TY Lee, JK Ho, M Sadatsafavi EClinicalMedicine 51, 2022 | 9 | 2022 |
Value-of-Information Analysis for External Validation of Risk Prediction Models M Sadatsafavi, TY Lee, L Wynants, AJ Vickers, P Gustafson Medical Decision Making 43 (5), 564-575, 2023 | 7 | 2023 |
Uncertainty and the value of information in risk prediction modeling M Sadatsafavi, T Yoon Lee, P Gustafson Medical Decision Making 42 (5), 661-671, 2022 | 6 | 2022 |
Cost-effectiveness of budesonide-formoterol vs inhaled epinephrine in US adults with mild asthma JK Ho, M Shaker, M Greenhawt, M Sadatsafavi, EM Abrams, ... Annals of Allergy, Asthma & Immunology 132 (2), 229-239. e3, 2024 | 5 | 2024 |
Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada JE Amegadzie, TY Lee, M Sadatsafavi, LD Lynd, DD Sin, KM Johnson CMAJ 195 (35), E1172-E1179, 2023 | 5 | 2023 |
16-year trends in asthma hospital admissions in Canada TY Lee, J Petkau, N Mangat, A Safari, JJ Cragg, LD Lynd, JM FitzGerald, ... Annals of Allergy, Asthma & Immunology 129 (4), 475-480. e2, 2022 | 5 | 2022 |
Long-term natural history of severe asthma exacerbations and their impact on the disease course TY Lee, J Petkau, M Sadatsafavi Annals of the American Thoracic Society 19 (6), 907-915, 2022 | 5 | 2022 |
QRISK3 underestimates the risk of cardiovascular events in patients with COPD JE Amegadzie, Z Gao, JK Quint, R Russell, JR Hurst, TY Lee, DD Sin, ... thorax, 2023 | 4 | 2023 |
Dimensional analysis in statistical modelling TY Lee, JV Zidek, N Heckman arXiv preprint arXiv:2002.11259, 2020 | 3 | 2020 |
Closed-Form Solution of the Unit Normal Loss Integral in 2 Dimensions, with Application in Value-of-Information Analysis TY Lee, P Gustafson, M Sadatsafavi, ... Medical Decision Making 43 (5), 621, 2023 | 2 | 2023 |
Development of a conceptual model of childhood asthma to inform asthma prevention policies A Adibi, SE Turvey, TY Lee, MR Sears, AB Becker, PJ Mandhane, ... BMJ Open Respiratory Research 8 (1), e000881, 2021 | 2 | 2021 |
Smarter Parking: Using AI to Identify Parking Inefficiencies in Vancouver D Graham, SK Sarraf, T Lundy, A MohammadMehr, S Uppal, TY Lee, ... arXiv preprint arXiv:2003.09761, 2020 | 1 | 2020 |
International Variation in Exacerbation Rates in Patients With Severe Asthma CP Yadav, TY Lee, DB Price, R Roy, LLH Mien, E Wang, ME Wechsler, ... D22. ADVANCES IN HEALTH SERVICES RESEARCH IN ASTHMA, A7021-A7021, 2024 | | 2024 |
Development and Validation of an Individualised Risk Prediction Model for Exacerbations in Patients With Severe Asthma in Real-world Settings W Chen, D Price, CP Yadav, RW Beasley, C Janson, TY Lee, ... C102. CLINICAL AND TRANSLATIONAL ADVANCES IN ASTHMA, A6700-A6700, 2024 | | 2024 |
Lung function as independent predictor of cardiovascular disease risk: implications for practice and policy TY Lee, M Sadatsafavi Thorax 79 (3), 196-197, 2024 | | 2024 |
International variation in severe exacerbation rates in patients with severe asthma TY Lee, D Price, CP Yadav, R Roy, LLH Mien, E Wang, ME Wechsler, ... Chest, 2024 | | 2024 |
The expected value of sample information calculations for external validation of risk prediction models M Sadatsafavi, AJ Vickers, TY Lee, P Gustafson, L Wynants arXiv preprint arXiv:2401.01849, 2024 | | 2024 |
Development and Validation of an Asthma Policy Model for Canada: Lifetime Exposures and Asthma outcomes Projection (LEAP) TY Lee, J Petkau, KM Johnson, S Turvey, A Adibi, P Subbarao, ... medRxiv, 2024.03. 11.24304122, 2024 | | 2024 |